Dell   Report issue

For profit Phase 1
Founded: Round Rock TX United States (1984)
Status: No NME R&D (1984)

Organization Overview

First Clinical Trial
2015
NCT02559778
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuroblastoma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 7